Published in Acta Neuropathol on January 01, 1986
Iodine-125 brachytherapy for brain tumours--a review. Radiat Oncol (2012) 0.96
The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem (1970) 20.22
A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (1983) 6.52
Effects of alpha particle radiation on the rat brain, including vascular permeability and glycogen studies. J Neuropathol Exp Neurol (1961) 2.12
Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol (1981) 1.58
Differentiation of a bipotential glial progenitor cell in a single cell microculture. Nature (1985) 1.37
The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer (1979) 1.36
Ultrastructural observations on the transvascular route of protein removal in vasogenic brain edema. Acta Neuropathol (1985) 1.17
Relationship between specific gravity, water content, and serum protein extravasation in various types of vasogenic brain edema. Acta Neuropathol (1984) 1.12
Interstitial irradiation of brain tumors: a review. Neurosurgery (1981) 1.11
Uptake of macromolecules into neurons from a focal vasogenic cerebral edema and subsequent axonal spread to other brain regions. A preliminary study in the mouse with horseradish peroxidase as a tracer. Acta Neuropathol (1982) 1.00
Sequential morphological changes in the dog brain after interstitial iodine- 125 irradiation. Neurosurgery (1983) 0.84
Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue. Acta Neurochir (Wien) (1981) 0.83
Human central nervous system lesions following radiation therapy. Zentralbl Neurochir (1977) 0.81
The three-dimensional dose distribution of 125I seeds in tissue. Phys Med Biol (1983) 0.80
Fine-structure of bilateral radionecrosis in the dorsal hippocampus. Acta Neuropathol (1972) 0.79
Iodine-125 interstitial irradiation of virally induced dog brain tumours. Neurol Res (1984) 0.79
Radiation brain edema. Adv Neurol (1980) 0.78
Radiation effects of iridium-192 implants in the cat brain. Nuklearmedizin (1982) 0.78
Effects of single dose supervoltage whole brain radiation in Macaca mulatta. J Neuropathol Exp Neurol (1977) 0.77
Astrocytes induce blood-brain barrier properties in endothelial cells. Nature (1987) 4.70
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
Hans-Joachim Scherer (1906-1945), pioneer in glioma research. Brain Pathol (1999) 2.20
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol (1986) 2.07
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS). Acta Neuropathol (1985) 1.76
The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer (1999) 1.76
Carcinogenicity of N-methyl-N-nitrosourea: possible role of excision repair of O6-methylguanine from DNA. J Natl Cancer Inst (1974) 1.76
Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component. Acta Neuropathol (1991) 1.72
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis (2001) 1.71
Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Cancer Res (1997) 1.71
Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest (2000) 1.59
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Genetic profile of gliosarcomas. Am J Pathol (2000) 1.57
Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol (1993) 1.57
Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest (2001) 1.54
Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol (1999) 1.54
PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol (1998) 1.52
Reversibility of ischemic brain damage. Arch Neurol (1973) 1.48
p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res (1992) 1.48
p53 mutations in nonastrocytic human brain tumors. Cancer Res (1991) 1.42
APC mutations in sporadic medulloblastomas. Am J Pathol (2000) 1.40
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg (1988) 1.40
More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (2000) 1.39
Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol (1990) 1.38
Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene (1999) 1.37
Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol (1986) 1.35
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res (2000) 1.35
Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog (1993) 1.32
Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg (1993) 1.29
Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (1989) 1.27
p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol (2001) 1.27
Stereotactic biopsy of brain tumors. Surg Neurol (1980) 1.25
Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N-nitrosourea. Biochem J (1975) 1.24
Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol (1995) 1.23
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Oncogene (2000) 1.20
Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol (1997) 1.19
Differentiation in the medulloblastoma. A histological and immunohistochemical study. Acta Neuropathol (1987) 1.19
Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol (1997) 1.19
Growth rate of human pituitary adenomas. J Neurosurg (1987) 1.17
Atypical central neurocytoma. J Neuropathol Exp Neurol (1997) 1.17
O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts. J Neurosurg (1989) 1.15
[Morphology and growth of tumors of the nervous system produced transplacentally by ethylnitroso-urea]. Verh Dtsch Ges Pathol (1968) 1.15
Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J Neurochem (1974) 1.14
O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors. Carcinogenesis (1984) 1.14
Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol (1997) 1.14
Protein synthesis in the cat brain after prolonged cerebral ischemia. Brain Res (1971) 1.12
Hypotensive brain stem necrosis or cardiac arrest encephalopathy? Acta Neuropathol (1980) 1.11
Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Am J Pathol (1999) 1.11
The p53 gene and its role in human brain tumors. Glia (1995) 1.11
Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer (1989) 1.09
Resuscitation of the monkey brain after one hour complete ischemia. III. Indications of metabolic recovery. Brain Res (1975) 1.08
Akinetic mutism in bilateral necrotizing leucoencephalopathy after radiation and chemotherapy: electrophysiological and autopsy findings. J Neurol (1992) 1.07
Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genes. Int J Cancer (2001) 1.06
Chemical carcinogenesis in the nervous system. Int Rev Exp Pathol (1976) 1.05
Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropathol Exp Neurol (2000) 1.04
Morphological markers in neuro-oncology. Curr Top Pathol (1987) 1.04
Lipomatous medulloblastoma in adults. A distinct clinicopathological entity. Am J Surg Pathol (1996) 1.04
The effect of ischaemia and recirculation on protein synthesis in the rat brain. J Neurochem (1977) 1.04
Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas. J Neuropathol Exp Neurol (1998) 1.03
Genetic profile of the giant cell glioblastoma. Lab Invest (1999) 1.02
Exhaustion and recovery of repair excision of O6-methylguanine from rat liver DNA. Nature (1976) 1.02
p53 mutations in primary human lung tumors and their metastases. Mol Carcinog (1994) 1.02
Loss of DCC expression and glioma progression. Cancer Res (1997) 1.01
Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg (1990) 1.00
The endothelin system in human glioblastoma. Lab Invest (2000) 1.00
Human astrocytic brain tumors express AP02L/TRAIL. Acta Neuropathol (1999) 0.99
Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol (1994) 0.99
Long-term persistence of O6-methylguanine in rat brain DNA. Nature (1977) 0.99
p53 mutations in sporadic adrenocortical tumors. Int J Cancer (1993) 0.98
Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol (1997) 0.98
Histogenesis and differentiation potential of central neurocytomas. Lab Invest (1991) 0.96
Do Rosenthal fibers contain glial fibrillary acid protein? Acta Neuropathol (1981) 0.96
Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2). Acta Neuropathol (1989) 0.95
Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch (1995) 0.95
Morphology of malignant gliomas induced in rabbits by systemic application of N-methyl-N-nitrosourea. Z Neurol (1970) 0.95
Cell type-specific tumor induction in neural transplants by retrovirus-mediated oncogene transfer. Oncogene (1991) 0.95
Alkylation of rat brain nucleic acids by N-methyl-N-nitrosourea and methyl methanesulphonate. J Neurochem (1973) 0.95
Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res (1995) 0.94
Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas. J Neuropathol Exp Neurol (2001) 0.94
Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations. J Neuropathol Exp Neurol (1998) 0.94
Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas. Int J Cancer (1997) 0.94
Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol (2001) 0.94
Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89. Klin Padiatr (1998) 0.93
DNA alkylation and neuro-oncogenesis by 3,3-dimethyl-1-phenyltriazene. Acta Neuropathol (1978) 0.93
Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. Int J Cancer (1996) 0.93
Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes. Int J Cancer (1998) 0.93
In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC). Biochem Pharmacol (1986) 0.92
The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir (Wien) (1987) 0.92
p53 mutations versus EGF receptor expression in giant cell glioblastomas. J Neuropathol Exp Neurol (1997) 0.92
Intraoral malignant melanotic schwannoma. Ultrastructural evidence for melanogenesis by Schwann's cells. Arch Pathol Lab Med (1983) 0.92
Morphologic evaluation of stereotactic brain tumour biopsies. Acta Neurochir Suppl (Wien) (1984) 0.92
Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors. Cancer (1997) 0.91
Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67. Skull Base Surg (1991) 0.91
Cerebral protein synthesis during long-term recovery from severe hypoglycemia. J Cereb Blood Flow Metab (1986) 0.91
Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas. Acta Neuropathol (2001) 0.91
Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas. Neuropathol Appl Neurobiol (1994) 0.91